| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:42 | Fastenal stock rating reiterated at Underperform by Bernstein as CEO plans exit | ||
| 14:42 | Carnival stock rating reiterated at Market Perform by Bernstein SocGen | ||
| 14:42 | KeyBanc maintains Sector Weight rating on Lifecore Biomedical stock | ||
| 14:42 | Bernstein reiterates Gilead Sciences stock rating, citing minimal Medicaid impact | ||
| 14:42 | Petronet LNG stock poised for growth as global LNG supply rises | ||
| 14:30 | Johnson & Johnson completes $3.05 billion acquisition of Halda Therapeutics | ||
| 14:30 | FDA accepts INOVIO's BLA for RRP treatment, sets October 2026 target date | ||
| 14:30 | China approves first community use epinephrine nasal spray for allergies | ||
| 14:30 | Motiva implants submitted to FDA for breast reconstruction approval | ||
| 14:30 | SQD Network launches revenue pools to fund data infrastructure | ||
| 14:30 | Ooma completes acquisition of Phone.com for $23.2 million | ||
| 14:30 | BGC reaffirms Q4 2025 outlook | ||
| 14:30 | Study finds babesia infection in 24% of chronic fatigue patients | ||
| 14:30 | VCI Global to acquire 51% stake in Mexican automotive platform | ||
| 14:30 | Enveric Biosciences receives new patent for neuropsychiatric treatments | ||
| 14:18 | Datavault AI sets Jan. 7 record date for warrant dividend | ||
| 14:18 | Tonix Pharmaceuticals secures $20 million investment from Point72 | ||
| 14:18 | Lamb Weston stock price target lowered to $46 from $65 at Bernstein | ||
| 14:18 | Needham raises Autolus Therapeutics stock price target on Aucatzyl launch success | ||
| 14:18 | Bernstein lowers ConAgra stock price target to $18 on mixed quarter | ||
| 14:18 | Diageo stock price target lowered to $124 by Bernstein on EABL sale | ||
| 14:06 | Tonix Pharmaceuticals advances TNX-4800 for Lyme disease prevention | ||
| 14:06 | Fusion Fuel subsidiary signs €30 million hydrogen project platform deal | ||
| 14:06 | D. Boral Capital initiates Turn Therapeutics stock with Buy rating | ||
| 14:06 | Stephens maintains Okta stock rating, sees growth potential in Auth0 |